Radiation: 1,109 Real Stories

1,109 stories match radiation. 868 of them mention chemotherapy.

Dorian, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Dorian's Survivor Story

Patient Info: Dorian de Salvo, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of March 2024, Dorian had a complete response to TCHP chemotherapy, clear surgical margins, and no lymph-node involvement after surgery, with radiation completed and additional care still expected for several months.

The Patient Story
OutcomeCancer-Free / NED
Justine, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IIIB to metastatic rectal cancer: setback and treatment journey

Patient Info: Justine, Female, Under 40 | Stage IV

Metastatic Site: Liver; lung

As of March 2024, Justine was living with metastatic rectal cancer involving liver and lung, described as treatable but not curable, after surgery, permanent ileostomy, IV chemotherapy, liver ablation, lung SBRT, and Y-90 liver radioembolization.

The Patient Story
OutcomeLiving With Cancer
Jason, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Jason Randall: stage IV colorectal cancer and liver metastases

Patient Info: Jason Randall, Male, Under 40 | Stage IV

Metastatic Site: Liver; lung; tailbone/sacrum/pelvis

As of March 2024, Jason was 2.5 years off chemotherapy and 16 months with no evidence of disease after treatment for Stage IV rectosigmoid colorectal cancer.

City of Hope
OutcomeCancer-Free / NED
Stephanie, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Stephanie's Patient Story

Patient Info: Stephanie McBride, 40s

After chemotherapy, surgery, radiation, and a temporary ileostomy, Stephanie continued managing neuropathy, pain, and increased anxiety.

Fight Colorectal Cancer
OutcomeNot reported
Loriana, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Loriana's Survivor Story

Patient Info: Loriana, Female

Biomarkers: Breast cancer biomarkers not reported

As of February 2024, Loriana was surviving after AML and later breast cancer, while living with chronic pain, depression, PTSD, and a strong advocacy role focused on patient support and self-advocacy.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Debbie, who was diagnosed with Stage I Breast AdenocarcinomaBreast Cancer

Stage I Breast Adenocarcinoma: Debbie's Survivor Story

Patient Info: Debbie Wade, Female | Stage I

As of February 2024, Debbie was cancer-free after double mastectomy, 4 weeks of radiation therapy and DIEP flap reconstruction for Stage I mucinous adenocarcinoma of the left breast, with mild left-arm lymphedema as the only reported side effect.

MD Anderson
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

EGFR-mutated stage IV lung cancer complicated by radiation lung injury and severe COVID-19

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: EGFR mutation; TP53 mutation

Metastatic Site: bone

Osimertinib produced a significant reduction in the lung lesions. She remained alive at the last follow-up in July 2023 after recovering from severe COVID-19 and treatment-related lung complications.

PubMed Central
OutcomeResponding Well
Dena, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV BRCA Breast Cancer: Dena's Patient Story

Patient Info: Dena Ofengeim, Under 40 | Stage IV

Biomarkers: Hormone receptor-positive; BRCA mutation

Metastatic Site: spine

Dena improved rapidly after treatment, regained her mobility, returned to an active life, and remained on therapy for metastatic breast cancer.

Dana-Farber
OutcomeResponding Well
Bobbi, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Bobbi's Survivor Story

Patient Info: Bobbi Ratliff, 50s | Stage IV

Metastatic Site: liver|lungs

On February 1, 2024, scans showed no evidence of cancer after multimodal treatment for Stage IV disease.

Fight Colorectal Cancer
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Male Invasive Lobular Breast Cancer With a Pathogenic PALB2 Variant

Patient Info: Anonymized, male, 40s

Biomarkers: ER-positive; PR-positive; HER2 not amplified; pathogenic PALB2 variant

He was disease-free at 1-year follow-up after mastectomy, chemotherapy, and radiotherapy.

PubMed Central
OutcomeCancer-Free / NED
Jelena, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jelena's Survivor Story

Patient Info: Jelena, Female, Under 40 | Stage III

As of January 2024, Jelena was on annual follow-up after Stage III rectal cancer treatment, with her latest colonoscopy showing no polyps or suspicious findings.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal Squamous Cell CarcinomaColorectal Cancer

Understanding rectal squamous cell carcinoma, a rare form of rectal cancer

Patient Info: Anonymized, Female

Biomarkers: SCC antigen 0.6 ng/mL at 6-month response assessment

A complete response was established at 6 months, and she remained without clinical, laboratory or imaging evidence of disease 2 years after treatment.

PubMed Central
OutcomeCancer-Free / NED
Deborah, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Deborah's Patient Story

Patient Info: Deborah Persinger, Female, 70+ | Stage IV

Metastatic Site: Brain

As of January 2024, Deborah was living actively 13 years after lung cancer diagnosis, with recurrent brain metastases managed through repeated Gamma Knife radiosurgery and ongoing MRI surveillance.

Cleveland Clinic
OutcomeLiving With Cancer
Jason, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jason's Patient Story

Patient Info: Jason Reese, Male, 40s | Stage IV

Metastatic Site: Liver

As of January 2024, Jason still had active Stage IV rectal cancer, but extensive liver metastases had decreased from innumerable lesions to very few visible on scans, and treatment planning continued.

The Patient Story
OutcomeResponding Well
A patient, who was diagnosed with Stage IV Lung AdenocarcinomaLung Cancer

Rare lung cancer first discovered as a mass in the skull

Patient Info: Anonymized, Male | Stage IV

Biomarkers: KRAS ; CK7-positive; CDX2-positive; pathology favoured pulmonary enteric adenocarcinoma

Metastatic Site: skull base / sphenoid sinus; right posterior acetabulum

He received palliative radiation and prolonged systemic therapy, completing 35 cycles including 31 maintenance cycles of pemetrexed and pembrolizumab.

PubMed Central
OutcomeNot reported
Sally, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Invasive Lobular Carcinoma: Sally's Survivor Story

Patient Info: Sally Johnston, 70+

Biomarkers: Estrogen receptor-positive

Sally was in remission by the end of 2014 and remained active about 10 years after treatment.

Dana-Farber
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

Aggressive breast cancer presenting with severe skin infection

Patient Info: Anonymized, Female

Biomarkers: ER 99% positive; PR 99% positive; HER2 1+ / negative; Ki-67 3%; grade 2; 3 interpectoral lymph nodes negative; later axillary-node biopsy benign

She recovered from sepsis and surgery, had no distant metastases and a benign axillary-node biopsy, and was receiving adjuvant radiation with anastrozole ongoing.

PubMed Central
OutcomeCare Ongoing
Jim, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jim's Patient Story

Patient Info: Jim Bromwich, Male, Under 40 | Stage IV

Metastatic Site: Lung

As of January 2024, he had completed focused radiation to an isolated lung nodule and was awaiting follow-up scans; another tiny lung nodule was being monitored but was not PET-avid.

The Patient Story
OutcomeCare Ongoing
Gail, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Gail's Patient Story

Patient Info: Gail, Female, 60s | Stage III

Biomarkers: Luminal A

As of 2024, Gail had Stage III luminal A breast cancer and was awaiting the start of planned treatment with lumpectomy, radiation therapy, chemotherapy, and hormone therapy.

Our Cancer Stories
OutcomeCare Ongoing